Robinson James A. Jr. — SEC insider filings
SEC reporting owner CIK 1734295. 18 insider filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2021-01-12 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | Director | 10 | — | — | 16 |
| Eledon Pharmaceuticals, Inc. (ELDN) | Director | 3 | — | — | 5 |
| Urovant Sciences Ltd. (UROV) | PEO;CEO/Urovant Sciences, Inc., Director | 2 | — | — | 5 |
| Neos Therapeutics, Inc. (NEOS) | Director | 1 | — | — | 3 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Director | 2 | — | — | 2 |
Insider filings — Robinson James A. Jr.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Eledon Pharmaceuticals, Inc. (ELDN) | Option exercise (M): 3,430 @ $0 · Option exercise (M): 3,430 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/award (A): 30,870 (derivative) @ $0 · Grant/award (A): 3,430 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/award (A): 150,437 (derivative) @ $1.55 | EDGAR |
| 2023-09-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4/A | UroGen Pharma Ltd. (URGN) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-27 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-12-01 | 4 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2021-12-02 | 4 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Urovant Sciences Ltd. (UROV) | Disposition to issuer (D): 8,385 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 845,732 (derivative) @ $0 | EDGAR |
| 2021-03-19 | 4 | Neos Therapeutics, Inc. (NEOS) | Disposition to issuer (D): 23,453 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 46,907 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Urovant Sciences Ltd. (UROV) | Tax withholding (F): 4,095 @ $16.11 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734295 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs